Canadian supportive care recommendations for the management of neutropenia in patients with cancer.
about
An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACTClinical predictive models for chemotherapy-induced febrile neutropenia in breast cancer patients: a validation study.Advances in the treatment of neutropenia.Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications.Supportive Care Costs Associated with Second-Line Chemotherapy in Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study.Impact of granulocyte colony-stimulating factors in metastatic colorectal cancer patients.Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell FunctionThe use of granulocyte colony-stimulating factors in a Canadian outpatient setting.Gastrointestinal complications in children with acute myeloid leukemia.Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.Chemotherapy-induced myelotoxicity and incidence of lung metastasis in an animal model.Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor.Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia/lymphoma study group B-NHL03 study.
P2860
Q33425372-5486CF14-294C-4B84-A274-EA676BCCF932Q33778817-29D096C9-0C42-4FFA-A9DA-3C7869427A8DQ34609244-5E630886-3082-4727-B1EA-38EA0ED80358Q34620664-EEC099B4-D0F1-435D-9DFE-F22811711C21Q36942871-8CE9AD5A-CF9B-4D74-B18A-E39F673B8330Q37577685-793E7BB7-4C6E-45C2-B1AF-C492DD85B234Q37608249-85BD8707-CA77-48D8-96D6-ED0275687287Q37719624-AAB0D8E2-0AED-4C81-A5EC-0C59AFE5F3BEQ37720759-75D8B27E-7477-4A9C-BCB0-D98D7B439482Q38705873-3465A0C7-4CB3-4295-907E-6936951B3605Q39680258-DDD8CA95-E018-4C1E-8312-E57DC6A0BFF2Q40094120-2798DF6F-A2A1-4C4F-9290-24D00CBE6861Q40861075-AAA03851-1A38-42CC-A9C9-77F7E0379D06
P2860
Canadian supportive care recommendations for the management of neutropenia in patients with cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Canadian supportive care recom ...... penia in patients with cancer.
@ast
Canadian supportive care recom ...... penia in patients with cancer.
@en
type
label
Canadian supportive care recom ...... penia in patients with cancer.
@ast
Canadian supportive care recom ...... penia in patients with cancer.
@en
prefLabel
Canadian supportive care recom ...... penia in patients with cancer.
@ast
Canadian supportive care recom ...... penia in patients with cancer.
@en
P2093
P2860
P356
P1433
P1476
Canadian supportive care recom ...... penia in patients with cancer.
@en
P2093
C Desbiens
C T Kouroukis
P2860
P356
10.3747/CO.2008.198
P577
2008-01-01T00:00:00Z